Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,442
datasets available to search
ShareScore release 0.9.0
Dataset results
2,442 results for “Car”
EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
ClinicalTrials.gov study NCT02664363. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06017258. IPD Sharing: YES. Countries: 1. Publications: 1.
Cluster of Differentiation Antigen 19/22(CD19/22) CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT03287817. IPD Sharing: Not stated. Countries: 2. Publications: 2.
APRIL CAR T Cells (AUTO2) Targeting BCMA and TACI for the Treatment of Multiple Myeloma
ClinicalTrials.gov study NCT03287804. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies
ClinicalTrials.gov study NCT03056339. IPD Sharing: Not stated. Countries: 1. Publications: 2.
CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
ClinicalTrials.gov study NCT01454596. IPD Sharing: NO. Countries: 1. Publications: 5.
CAR-37 T Cells in Hematologic Malignancies
ClinicalTrials.gov study NCT04136275. IPD Sharing: YES. Countries: 1. Publications: 2.
Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)
ClinicalTrials.gov study NCT06004167. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis
ClinicalTrials.gov study NCT06371040. IPD Sharing: YES. Countries: 1. Publications: 0.
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
ClinicalTrials.gov study NCT03448393. IPD Sharing: YES. Countries: 1. Publications: 4.
A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy
ClinicalTrials.gov study NCT04148430. IPD Sharing: YES. Countries: 1. Publications: 1.
CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma
ClinicalTrials.gov study NCT00924326. IPD Sharing: NO. Countries: 1. Publications: 10.
Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian
ClinicalTrials.gov study NCT04670068. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma
ClinicalTrials.gov study NCT04097301. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03548207. IPD Sharing: Not stated. Countries: 2. Publications: 11.
Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy
ClinicalTrials.gov study NCT07173166. IPD Sharing: NO. Countries: 1. Publications: 4.
A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethason
ClinicalTrials.gov study NCT04181827. IPD Sharing: YES. Countries: 16. Publications: 8.
Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell
ClinicalTrials.gov study NCT03019055. IPD Sharing: NO. Countries: 1. Publications: 4.
InterMob: a Randomized Controlled Trial Aimed at Reducing Car Use in Regular Car Users
ClinicalTrials.gov study NCT05096000. IPD Sharing: YES. Countries: 1. Publications: 1.
MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT03585764. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.